The mechanism of alteronol inhibiting the proliferation of human promyelocytic leukemia HL-60 cells

Yaoxue Xuebao

Volumn 47, Issue 11, 2012, Pages 1477-1482

  Liu, Liang Liang ^a   Chen, Na ^a   Yuan, Xuan ^b   Yao, Ying ^c   Zhang, Bo ^a   Zheng, Qiu Sheng ^a  

^a SHIHEZI UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c Ningxia People's Hospital   (China)

Author keywords

Alteronol; Apoptosis; Cell cycle; Differentiation; HL 60

Indexed keywords

ACRIDINE ORANGE; ALTERONOL; ANTINEOPLASTIC AGENT; ETHIDIUM BROMIDE; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; NAPHTHOQUINONES; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN;

EID: 84872546818     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Miller MC 3rd, Johnson KR, Willingham MC, et al. Apoptotic cell death induced by baccatin III, a precursor of paclitaxel, may occur without G2/M arrest [J]. Cancer Chemoth Pharm, 1999, 44: 444-452.
2. Shu CH, Yang WK, Shi YL, et al. Cell cycle G2/M arrest and activation of cyclin-dependent kinases associated with low-dose paclitaxel-induced sub-G1 apoptosis [J]. Apoptosis, 1997, 2: 463-470.
3. 2M cell cycle arrest, and apoptosis induced by the novel compound alternol in human gastric carcinoma cell line MGC803 [J]. Invest New Drugs, 2007, 25: 505-517.
4. Liu ZZ, Chen JP, Zhao SL, et al. Apoptosis-inducing - effect of alternol on mouse lymphocyte leukemia cells and its mechanism [J]. Acta Pharm Sin, 2007, 42: 1259-1265.
5. Philip S, Ritsa S, Dominic S, et al. New colorimetric cytotoxicity assay for anticancer-drug screening [J]. Natl Cancer Inst, 1990, 82: 1107-1112.
6. Renzi D, Valtolina M, Foster R. The evaluation of a multi-end-point cytotoxicity assay system [J]. Altern Lab Anim, 1993, 21: 89-96.
7. Martinez VG, Williams KJ, Stratford IJ, et al. Overexpression of cytochrome P450 NADPH reductase sensitizes MDA231 breast carcinoma cells to 5-fluorouracil: possible mechanisms involved [J]. Toxicoll In Vitro, 2008, 22: 582-588.
8. Xie SQ, Li Q, Zhang YH, et al. NPC-16, a novel naphthalimide-polyamine conjugate, induced apoptosis and autophagy in human hepatoma HepG2 cells and Be1-7402 cells [J]. Apoptosis, 2011, 16: 27-34.
9. Wang N, Wang LW, Gou BD, et al. Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells [J]. Cell Biol Int, 2008, 32: 1497-1505.
10. Chen HY, Liu WH, Qin SK. Induction of arsenic trioxide on apoptosis of hepatocarcinoma cell lines [J]. World Chin J Digestol, 2000, 8: 532.
11. Tan TT, White E. Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells [J]. Adv Exp Med Biol, 2008, 615: 81-104.
12. Melet A, Song K, Bucur O, et al. Apoptotic pathways in tumor progression and therapy [J]. Adv Exp Med Biol, 2008, 615: 47-79.
13. Swanton C. Cell-cycle targeted therapies [J]. Lancet Oncol, 2004, 5: 27-36.
14. Blain SW, Scher HI, Cordon-Cardo C, et al. p27 as a target for cancer therapeutics [J]. Cancer Cell, 2003, 3: 111-115.
15. Guney I, Wu S, Sedivy JM. Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16 (INK4a) [J]. Proc Natl Sci Acad USA, 2006, 103: 3645-3650.
16. Zhang XM, Gao N, Chen RX, et al. Characteristics of boningmycin induced cellular senescence of human tumor cells [J]. Acta Pharm Sin, 2010, 45: 589-594.